Sheetal Chaurasia

Papers

Total Citations

H-Index

About

Sheetal Chaurasia is a rising voice in thoracic oncology, with a focused research agenda on improving outcomes for patients with lung cancer and other thoracic malignancies. Her most-cited work, a synthesis of the Thoracic Oncology Assembly’s highlights from the 2024 European Respiratory Society (ERS) Congress, distills cutting-edge global advances in the field—from novel immunotherapies to early detection strategies. This paper, already garnering 2 citations shortly after publication, underscores her ability to translate complex conference proceedings into actionable insights for the clinical and research community. Chaurasia’s contributions are particularly notable for bridging the gap between international expert consensus and practical application, addressing the immense pressure thoracic malignancies place on healthcare systems worldwide. Her work reflects a commitment to tackling lung cancer—the leading cause of cancer-related mortality—through evidence synthesis and collaborative knowledge exchange. As an emerging scholar, Chaurasia is positioning herself at the forefront of translational research, with a clear trajectory toward shaping future guidelines and therapeutic strategies in thoracic oncology.